928 Acknowledgments This research was supported by the Netherlands Organisation for Scientiﬁc Research (NWO), de ‘Hersenstichting Nederland’ and ‘Het Jan Jongmanfonds’. The authors are thankful for all Down syndrome persons for their participation in the study. Authors are also indebted to Mrs A.C.C. Voskuilen-Kooijman for her skilled technical assistance. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which per- mits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. References Akomolafe A, Lunetta KL, Erlich PM, Cupples LA, Baldwin CT, Huyck M, Green RC, Farrer LA (2006) Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin Genet 1(70):49–56. doi:10.1111/j.1399-0004.2006.00638.x Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A (2004) Nitric oxide as a physiopathological factor in neuropsychiatric disor- ders. In Vivo 3(18):377–390 Aylward EH, Burt DB, Thorpe LU, Lai F, Dalton A (1997) Diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res 41(Pt 2):152–164 Bernstein HG, Heinemann A, Krell D, Dobrowolny H, Bielau H, Keilhoff G, Bogerts B (2005) Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell Mol Biol (Noisy-le-grand) 3(51):279–284 Burt DB, Aylward EH (2000) Test battery for the diagnosis of dementia in individuals with intellectual disability: working group for the establishment of criteria for the diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res 44(Pt 2):175–180 Cheon MS, Dierssen M, Kim SH, Lubec G (2008) Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids 35(2):339–343 Coppus A, Evenhuis H, Verberne GJ, Visser F, van Gool P, Eikelenboom P, van Duijn C (2006) Dementia and mortality in persons with Down’s syndrome. J Intellect Disabil Res 50(Pt 10):768–777. doi:10.1111/j.1365-2788.2006.00842.x Coppus AW, Fekkes D, Verhoeven WM, Tuinier S, Egger JI, van Duijn CM (2007) Plasma amino acids and neopterin in healthy persons with Down’s syndrome. J Neural Transm 8(114):1041– 1045. doi:10.1007/s00702-007-0656-1 Coppus AM, Fekkes D, Verhoeven WM, Tuinier SA, van Duijn CM (2009) Neopterin and the risk of dementia in persons with Down syndrome. doi:10.1016/j.neulet.2009.04.020 Fekkes D, van Dalen A, Edelman M, Voskuilen A (1995) Validation of the determination of amino acids in plasma by high- performance liquid chromatography using automated pre-col- umn derivatization with o-phthaldialdehyde. J Chromatogr B Biomed Appl 2(669):177–186. doi:10.1016/0378-4347(95) 00111-U Fekkes D, Bannink M, Kruit WH, Van Gool AR, Mulder PG, Sleijfer S, Eggermont AM, Stoter G (2007) Inﬂuence of pegylated interferon-alpha therapy on plasma levels of citrulline and arginine in melanoma patients. Amino Acids 1(32):121–126. doi:10.1007/s00726-006-0284-3 Hoekstra R, van den Broek WW, Fekkes D, Bruijn JA, Mulder PG, Pepplinkhuizen L (2001) Effect of electroconvulsive therapy on 123 A. M. W. Coppus et al. biopterin and large neutral amino acids in severe, medication- resistant depression. Psychiatry Res 2–3(103):115–123. doi: 10.1016/S0165-1781(01)00282-7 Hull M, Pasinetti GM, Aisen PS (2000) Elevated plasma neopterin levels in Alzheimer disease. Alzheimer Dis Assoc Disord 4(14):228–230. doi:10.1097/00002093-200010000-00007 Hunter AGW (2005) Down syndrome. Wiley-Liss, New Jersey Jose DG, Good RA (1973) Quantitative effects of nutritional essential amino acid deﬁciency upon immune responses to tumors in mice. J Exp Med 1(137):1–9. doi:10.1084/jem.137.1.1 Kakazu E, Kanno N, Ueno Y, Shimosegawa T (2007) Extracellular branched-chain amino acids, especially valine, regulate matura- tion and function of monocyte-derived dendritic cells. J Immunol 10(179):7137–7146 Li P, Yin YL, Li D, Kim SW, Wu G (2007) Amino acids and immune function. Br J Nutr 2(98):237–252. doi:10.1017/ S000711450769936X Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S (2007) Gene expression proﬁling in the adult Down syndrome brain. Genomics 6(90):647–660. doi:10.1016/j.ygeno. 2007.08.005 Louzada PR, Lima AC, Mendonca-Silva DL, Noel F, De Mello FG, Ferreira ST (2004) Taurine prevents the neurotoxicity of beta- amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer’s disease and other neurological disorders. FASEB J 3(18):511–518. doi: 10.1096/fj.03-0739com McGeer PL, McGeer EG (2004) Inﬂammation and the degenerative diseases of aging. Ann N Y Acad Sci (1035):104–116. doi: 10.1196/annals.1332.007 Mircher C, Salabelle A, Peeters MA, Rabier D, Parvy P, Kamoun P, Lejeune J (1997) Variation of amino acids in relation to age in Down syndrome subjects. [Variation des acides amines en fonction de l’age chez des sujets trisomiques 21]. Arch Pediatr 11(4):1093–1099. doi:10.1016/S0929-693X(97)88974-9 Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G (2008) Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 1(7):3–10 Murr C, Hainz U, Asch E, Berger P, Jenewein B, Saurwein-Teissl M, Grubeck-Loebenstein B, Fuchs D (2003) Association of increased neopterin production with decreased humoral immu- nity in the elderly. Exp Gerontol 5(38):583–587. doi:10.1016/ S0531-5565(03)00062-7 Ploder M, Neurauter G, Spittler A, Schroecksnadel K, Roth E, Fuchs D (2008) Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 35(2):303–307 Santa-Maria I, Hernandez F, Moreno FJ, Avila J (2007) Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid- beta-peptide aggregation. Neurosci Lett 2–3(429):91–94. doi: 10.1016/j.neulet.2007.09.068 Sharma JN, Al-Omran A, Parvathy SS (2007) Role of nitric oxide in inﬂammatory diseases. Inﬂammopharmacology 6(15):252–259. doi:10.1007/s10787-007-0013-x Shi W, Meininger CJ, Haynes TE, Hatakeyama K, Wu G (2004) Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem Biophys 3(41):415–434. doi: 10.1385/CBB:41:3:415 World Health Organization (1992) ICD-10: international statistical classiﬁcation of diseases and related health problems, 10th revision. WHO, Geneva